Is poorly differentiated lung cancer serious and what does poorly differentiated mean what does poor

Is it true that the pathological report of lung cancer is poorly differentiated, indicating a high degree of malignancy?

1. Cancer underdifferentiation is: Generally, cancer cells are mainly divided into four types according to the degree of differentiation of tissue cells, namely well-differentiated carcinoma, moderately differentiated carcinoma, poorly differentiated carcinoma and undifferentiated carcinoma.

2. Generally, the lower the degree of differentiation, the higher the degree of malignancy, so the low differentiation of cancer may mean that the degree of malignancy of the tumor is relatively high or the stage is relatively late, and it also depends on the size of the tumor lesion and whether there are metastatic lesions in other parts. Generally, if surgery can be done**, surgery is still done first**, including the enlarged excision of the entire mass plus dissection of the surrounding lymph nodes. Postoperative therapy and chemotherapy are also required.

Most of the poorly differentiated carcinomas are already in the middle and advanced stages when they are discovered, and distant metastasis may occur, and many have no chance of surgery, and the effect is generally not very good.

The differentiation of lung cancer from poorly differentiated lung adenocarcinoma refers to this: the lower the degree of differentiation, the greater the severity and the greater the difficulty. The degree of evilness is ranked from largest to smallest, in order:

Undifferentiated, poorly differentiated, moderately differentiated, and highly differentiated. Lung adenocarcinoma adopts the principle of comprehensive treatment, combined with surgery, radiotherapy, chemotherapy and other methods to achieve the purpose of inhibiting tumor progression with the greatest effect. At present, surgery is still the main treatment of lung adenocarcinoma.

Brain metastases in poorly differentiated lung adenocarcinoma are usually more serious, and it can be determined that the body is very weak and not suitable for surgery or excessive chemoradiotherapy, and forced chemoradiotherapy will do more harm than good. If it is necessary, the patient should be slightly stronger before doing it, but in moderation.

In fact, for the advanced metastasis of malignant tumors, whether surgery, radiotherapy or chemotherapy or not, it is basically impossible to completely remove the cancer cell virus from the patient's body.

When cancer cells have not spread or metastasized, they can be resected, and the rate of tumor multicellular immunity can remove cancer cells and small lesions remaining in surgery, enhance the body's immunity, restore surgical trauma, and effectively delay or prevent tumor metastasis. The combination of tumor multicellular biological immunity** before and after radiotherapy can further repair the damage caused by radiotherapy, prevent tumors** and metastasis after radiotherapy, and enhance the efficacy of radiotherapy.

Reasonable and effective technology can bring hope to patients, reduce patients' suffering, and continuously improve patients' conditions.

Low-grade adenocarcinoma is relative to well-differentiated adenocarcinoma and moderately differentiated adenocarcinoma, in contrast, the degree of differentiation of cancer cells is lower, and the immature form of similar tissues, such as low-differentiated adenocarcinoma, glandular duct and acinar structure basically disappears.

Generally speaking, well-differentiated adenocarcinoma has a low degree of malignancy and has a better prognosis, poorly differentiated adenocarcinoma has a high degree of malignancy and a poor prognosis, and undifferentiated adenocarcinoma has a very high degree of malignancy and has the worst prognosis. If there is anything you don't understand, you can ask.

Lung adenocarcinoma is a type of lung cancer, which is divided into small cell lung cancer and non-small cell lung cancer, non-small cell is divided into lung squamous cell carcinoma and lung adenocarcinoma, and lung cancer is divided into central lung cancer and peripheral lung cancer according to the location. More non-small cell lung cancer and lung adenocarcinoma are more common in women in non-smokers, so more lung adenocarcinoma is in female non-smokers, especially with CT screening and health examination, this small intrapulmonary nodule can be found to be more common in female non-smokers.